How to buy Masimo Corporation stock

Masimo Corporation is a medical instruments & supplies business based in the US. Masimo Corporation shares (MASI) are listed on the NASDAQ and all prices are listed in US Dollars. Masimo Corporation employs 1,600 staff and has a trailing 12-month revenue of around USD$1.1 billion.

How to buy shares in Masimo Corporation

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Masimo Corporation. Find the stock by name or ticker symbol: MASI. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Masimo Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Masimo Corporation, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Masimo Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Masimo Corporation share price

Use our graph to track the performance of MASI stocks over time.

Masimo Corporation shares at a glance

• Key figures

Information last updated 2020-11-26.

52-week range	USD$143.9 - USD$259.29
50-day moving average	USD$240.5758
200-day moving average	USD$230.4267
Wall St. target price	USD$279.33
PE ratio	63.3896
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$3.85

Buy Masimo Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Masimo Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Masimo Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Masimo Corporation under- or over-valued?

Valuing Masimo Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Masimo Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Masimo Corporation's P/E ratio

Masimo Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 63x. In other words, Masimo Corporation shares trade at around 63x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Masimo Corporation's PEG ratio

Masimo Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.6475. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Masimo Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Masimo Corporation's EBITDA

Masimo Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$279.1 million.

The EBITDA is a measure of a Masimo Corporation's overall financial performance and is widely used to measure a its profitability.

Masimo Corporation financials

Revenue TTM	USD$1.1 billion
Operating margin TTM	22.99%
Gross profit TTM	USD$629.2 million
Return on assets TTM	10.4%
Return on equity TTM	17.64%
Profit margin	20.3%
Book value	$25.698
Market capitalisation	USD$13.5 billion

TTM: trailing 12 months

Shorting Masimo Corporation shares

There are currently 1.2 million Masimo Corporation shares held short by investors – that's known as Masimo Corporation's "short interest". This figure is 7.1% down from 1.3 million last month.

There are a few different ways that this level of interest in shorting Masimo Corporation shares can be evaluated.

Masimo Corporation's "short interest ratio" (SIR)

Masimo Corporation's "short interest ratio" (SIR) is the quantity of Masimo Corporation shares currently shorted divided by the average quantity of Masimo Corporation shares traded daily (recently around 339584.89010989). Masimo Corporation's SIR currently stands at 3.64. In other words for every 100,000 Masimo Corporation shares traded daily on the market, roughly 3640 shares are currently held short.

However Masimo Corporation's short interest can also be evaluated against the total number of Masimo Corporation shares, or, against the total number of tradable Masimo Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Masimo Corporation's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Masimo Corporation shares in existence, roughly 20 shares are currently held short) or 0.0268% of the tradable shares (for every 100,000 tradable Masimo Corporation shares, roughly 27 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Masimo Corporation.

Find out more about how you can short Masimo Corporation stock.

Masimo Corporation share dividends

We're not expecting Masimo Corporation to pay a dividend over the next 12 months.

Masimo Corporation share price volatility

Over the last 12 months, Masimo Corporation's shares have ranged in value from as little as $143.9 up to $259.29. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Masimo Corporation's is 0.8523. This would suggest that Masimo Corporation's shares are less volatile than average (for this exchange).

Masimo Corporation overview

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. Additionally, the company offers Trace, a patient data visualization and reporting software for Masimo Root and Radical-7 monitors. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, home care providers, long term care facilities, veterinarians, and consumers. Masimo Corporation was founded in 1989 and is headquartered in Irvine, California.

Frequently asked questions

• What percentage of Masimo Corporation is owned by insiders or institutions?

  Currently 7.502% of Masimo Corporation shares are held by insiders and 84.288% by institutions.

• How many people work for Masimo Corporation?

  Latest data suggests 1,600 work at Masimo Corporation.

• When does the fiscal year end for Masimo Corporation?

  Masimo Corporation's fiscal year ends in December.

• Where is Masimo Corporation based?

  Masimo Corporation's address is: 52 Discovery, Irvine, CA, United States, 92618

• What is Masimo Corporation's ISIN number?

  Masimo Corporation's international securities identification number is: US5747951003

• What is Masimo Corporation's CUSIP number?

  Masimo Corporation's Committee on Uniform Securities Identification Procedures number is: 574795100